Cheryl Critchley: Ledger

Stories naming Cheryl Critchley. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Media Manager	Monash University	Brandon BioCatalyst portfolio, Brandon Capital portfolio

Funding announcement

QUE Oncology's non-hormonal therapy reduces hot flushes and night sweats in women with breast cancer, published in The Lancet

QUE Oncology reports its non-hormonal drug Q-122 eased hot flushes in breast cancer patients on endocrine therapy, with Phase II results in The Lancet; the Emory–UniQuest venture is backed by Brandon BioCatalyst and Uniseed.

Brandon BioCatalyst portfolio 11 Nov 2022 Brandon BioCatalyst Brandon Capital Emory University Mana Communications Monash University QUEoncologyHealthier menopause treatments UniQuest Uniseed University of Queensland Cheryl Critchley Dr Chris Nave Ciara Byrne Professor Susan Davis

Cheryl Critchley

Roles

Coverage

QUE Oncology's non-hormonal therapy reduces hot flushes and night sweats in women with breast cancer, published in The Lancet

QUE Oncology's non-hormonal therapy reduces hot flushes and night sweats in women with breast cancer, published in The Lancet